A single item for overall side effect impact: Association with clinician-reported adverse events and global health

20260 citationsJournal Articlegreen Open Access

Authors

Jessica Roydhouse · University of Tasmania

Anne Zola · Northwestern University

Monique Breslin · University of Tasmania

Ethan Basch · University of North Carolina at Chapel Hill

Melanie Calvert · NIHR Birmingham Biomedical Research Centre

David Cella · Northwestern University

Mary Lou Smith

Abstract

GP5 is associated with both clinician- and patient-reported symptoms, suggesting its validity and usefulness as part of comprehensive tolerability assessment of cancer trials.

Topics & Keywords

Pain Management and Placebo Effect Pharmacovigilance and Adverse Drug Reactions Cancer survivorship and care

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Trials

DOI: 10.1177/17407745251405412

Field-Weighted Citation Impact: 0.00